0001731122-22-000366.txt : 20220304 0001731122-22-000366.hdr.sgml : 20220304 20220304070027 ACCESSION NUMBER: 0001731122-22-000366 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220304 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANAVEX LIFE SCIENCES CORP. CENTRAL INDEX KEY: 0001314052 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 208365999 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37606 FILM NUMBER: 22712064 BUSINESS ADDRESS: STREET 1: 51 W 52ND STREET, STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019-6163 BUSINESS PHONE: 800-689-3939 MAIL ADDRESS: STREET 1: 51 W 52ND STREET, STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019-6163 FORMER COMPANY: FORMER CONFORMED NAME: Thrifty Printing Inc. DATE OF NAME CHANGE: 20050111 8-K 1 e3562_8-k.htm FORM 8-K
0001314052 false 0001314052 2022-03-04 2022-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 4, 2022

 

ANAVEX LIFE SCIENCES CORP.
(Exact name of registrant as specified in its charter)

 

Nevada 001-37606 98-0608404
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

630 5th Avenue, 20th Floor
New York, NY 10111

(Address of principal executive offices) (Zip Code)

  

1-844-689-3939

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange on Which Registered
Common Stock, par value $0.001 per share   AVXL   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

 

Item 4.01 Change in Registrant’s Certifying Accountant.

 

(a) Dismissal of Independent Registered Public Accounting Firm.

 

On March 1, 2022, the Audit Committee (the “Audit Committee”) of the Board of Directors of Anavex Life Sciences Corp., a Nevada corporation (the “Company”) dismissed BDO USA LLP (“BDO”) as the Company’s independent registered public accounting firm.

 

The reports of BDO on the Company’s consolidated financial statements for each of the two most recently completed fiscal years did not contain an adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles. During the fiscal years ended September 30, 2021 and 2020 and the subsequent interim period through March 1, 2022, there have been no disagreements with BDO on any matters of accounting principles or practices, financial statement disclosures or auditing scope and procedures that, if not resolved to the satisfaction of BDO, would have caused BDO to make reference to the matter in their reports. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the two most recently completed fiscal years ended September 30, 2021 and 2020, or in the subsequent interim period through March 1, 2022.

 

The Company has provided a copy of the foregoing disclosures to BDO and requested that BDO furnish it with a letter addressed to the Securities and Exchange Commission stating whether BDO agrees with the above statements. A copy of BDO’s letter, dated March 4, 2022, is filed as Exhibit 16.1 to this Form 8-K.

 

(b) Engagement of New Independent Registered Public Accounting Firm.

 

The Audit Committee has conducted a competitive process to select an accounting firm to serve as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2022. The Audit Committee invited several firms to participate in this process. As a result of this process, on March 3, 2022, the Audit Committee engaged Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2022.

 

  During the two most recently completed fiscal years and in the subsequent interim period through March 3, 2022, the Company has not consulted with Grant Thornton with respect to the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that would have been rendered on the Company’s consolidated financial statements, or any matters set forth in Item 304(a)(2)(i) or (ii) of Regulation S-K.

 

Item 5.02Compensatory Arrangements of Certain Officers

 

On February 28, 2022, the Company entered into Amendment No. 2 to the Amended and Restated Employment Agreement (the “Amendment”) with the Company’s Principal Financial Officer (the “PFO”) in her continuing capacity as PFO of the Company, to be effective March 1, 2022. The Amendment amends the Amended and Restated Employment Agreement by and between the Company and the PFO dated October 4, 2017, as amended (the “Employment Agreement”). Pursuant to the terms of the Amendment, the PFO shall receive an annual base salary of $240,000 Canadian dollars.

 

Item 7.01 Regulation FD Disclosure

 

On March 4, 2022, the Company issued a press release announcing the change in its auditors from BDO to Grant Thornton. The press release is attached as Exhibit 99.1.

 

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d)  Exhibits

 

EXHIBIT NO.   DESCRIPTION   LOCATION
10.1   Amendment No. 2 to Amended and Restated Employment Agreement between the Company and Sandra Boenisch, dated February 28, 2022   Filed herewith
16.1   Letter from BDO USA LLP to the Securities and Exchange Commission dated March 4, 2022   Filed herewith
99.1   Press Release   Filed herewith

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ANAVEX LIFE SCIENCES CORP.
   
  By:  /s/Christopher Missling
    Name: Christopher Missling, PhD
Title: Chief Executive Officer

 

Date: March 4, 2022

 

 

 

 

 EX-10.1 2 e3562_10-1.htm EXHIBIT 10.1

 

 

Exhibit 10.1

 

AMENDMENT NO. 2 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

THIS AMENDMENT NO. 2 (the “Amendment”) to the Amended and Restated Employment Agreement, dated October 4, 2017 (the “Employment Agreement”) is dated February 28, 2022 with an effective date of March 1, 2022, is by and between Anavex Life Sciences Corp. (the “Company” or “Anavex”), and Sandra Boenisch (the “Employee”). Except as otherwise provided herein in this Amendment, capitalized terms used in this Amendment shall have the same meanings given to them in the Employment Agreement. Company and the Employee are referred to each individually as a “Party” and collectively as the “Parties.”

 

RECITALS

 

WHEREAS, the Employee is currently employed by the Company as Principal Financial Officer pursuant to the terms of the Employment Agreement; and

 

WHEREAS, the Parties desire to amend the Employment Agreement as described below, but to otherwise maintain in effect in full all other terms of the Employment Agreement; and

 

NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, for the Parties agree as follows:

 

AMENDMENT

 

1.Adoption of Recitals. The Company and Employee adopt the above recitals as being true and correct

 

2.Section 1(a) Employment. The Parties agree that Section 1(a) of the Employment Agreement shall be amended and restated as follows:

 

“(a)         Employment. This Agreement will commence on March 1, 2022 (the “Effective Date”) and shall terminate on February 28, 2024 (the “Term”), unless sooner terminated in accordance with the provisions of this Agreement. The Term and any extensions shall be referred to as the “Employment Period.” This Agreement must be renewed in writing, signed by both parties. If the Agreement is not renewed in writing, the non-renewal is not considered a Termination.”

 

3.Section 3(a) Base Salary. The Parties agree that Section 3(a) of the Employment Agreement shall be amended and restated as follows:

 

“(a)         Base Salary. During the Employment Period, the Company shall pay to the Employee an annual base salary (“Base Salary”) of Two Hundred Forty Thousand Canadian Dollars ($240,000 CAD) payable by the Company and payable in accordance with the Company’s payroll schedules throughout the term of such employment, subject to the provisions of Section 4 hereof (governing Terminations), and subject to any applicable tax and payroll deductions; provided, however, that in the Company’s sole discretion, based on factors such as the market and the Employee’s job performance, salary increases may be made. There, however, is never a guarantee of an increase in Base Salary. Salary decreases may be made through a written modification of this Agreement executed and signed by the Parties.”

 

4.            Full Force and Effect. Except as expressly amended herein, all other terms and provisions of the Employment Agreement shall remain in full force and effect and are hereby ratified and confirmed in all respects. The Parties mutually acknowledge and agree that any and all other prior agreements, offer letters or contracts between Employee and the Company, are declared null and void with no legal effect as of the date this Amendment is executed by the Parties.

 

5.            Further Amendments. The Employment Agreement shall be further amended wherever appropriate to reflect the changes indicated above.

 

1
 

 

6.            Right to Review and Seek Counsel. The Employee acknowledges that she has had the opportunity to seek independent counsel and tax advice in connection with the execution of this Agreement, and the Employee represents and warrants to the Company (a) that she has sought such independent counsel and advice as she has deemed appropriate in connection with the execution hereof and the transactions contemplated hereby, and (b) that she has not relied on any representation of the Company as to tax matters, or as to the consequences of the execution hereof.

 

7.            Governing Law. This Amendment shall be governed and construed in accordance with the laws of the State of New York without regard to conflicts of law.

 

8.            Headings and Captions. The titles and captions of paragraphs, sections, subparagraphs and subsections contained in this Amendment are provided for convenience of reference only, and shall not be considered terms or conditions of this Amendment.

 

9.            Validity. The invalidity or unenforceability of any provision of this Amendment shall not affect the validity or enforceability of any other provision of this Amendment, which shall remain in full force and effect.

 

10.          Counterparts. This Amendment may be executed in one or more separate counterparts, each of which, when so executed, shall be deemed to be an original. Such counterparts shall, together, constitute and shall be one and the same instrument. This Amendment, and the counterparts thereto, may be executed by the Parties using their respective signatures transmitted via facsimile machines or via electronic mail.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement on February 28, 2022.

 

ANAVEX LIFE SCIENCES CORP.   SANDRA BOENISCH
       
By:  /s/Christopher Missling   /s/ Sandra Boenisch
       
Name: Christopher U. Missling    
       
Title: CEO    

 

2

 

 

 

 

 EX-16.1 3 e3562_ex16-1.htm EXHIBIT 16.1

 

 

EXHIBIT 16.1

 

March 4, 2022

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on March 1, 2022, to be filed by our former client, Anavex Life Sciences Corp.. We agree with the statements made in response to that Item insofar as they relate to our Firm.

 

Very truly yours,

/s/ BDO USA, LLP

 

 

 

 EX-99.1 4 e3562_ex99-1.htm EXHIBIT 99.1

 

 

EXHIBIT 99.1

 

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP

 

NEW YORK – March 4, 2022 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it has changed its auditors from BDO USA LLP (“BDO“) to Grant Thornton LLP (“Grant Thornton“).

 

The change in independent auditor was not related to any disagreement between the Company and BDO. The Company is thankful to BDO USA LLP for its 9 years of service as the Company’s independent auditor.

 

The change of the Company’s independent auditor was made after careful consideration and an evaluation process carried out by the Audit Committee of the Board of Directors of the Company.

 

“We would like to thank BDO USA LLP for the services they provided for almost a decade. We are pleased to announce that Grant Thornton LLP will be our new auditors in the evolution of Anavex as we embark upon the next stages of our Company’s growth plans,” stated Christopher U Missling, PhD, President and Chief Executive Officer of Anavex.

 

About Anavex Life Sciences Corp.

 

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex’s lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a clinical trial for Alzheimer’s disease, a Phase 2 proof-of-concept study in Parkinson’s disease dementia and both a Phase 2 and a Phase 3 study in adult patients with Rett syndrome. ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. ANAVEX®2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson’s Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 for the treatment of Parkinson’s disease. ANAVEX®3-71, which targets sigma-1 and muscarinic M1 receptors, is a promising clinical stage drug candidate demonstrating disease-modifying activity against the major hallmarks of Alzheimer’s disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. In preclinical trials, ANAVEX®3-71 has shown beneficial effects on mitochondrial dysfunction and neuroinflammation. Further information is available at www.anavex.com. You can also connect with the company on Twitter, Facebook, Instagram and LinkedIn.

 

 

 

 

Forward-Looking Statements

 

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks set forth in the Company’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Anavex Life Sciences Corp. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

 

For Further Information:

 

Anavex Life Sciences Corp.

Research & Business Development

Toll-free: 1-844-689-3939

Email: info@anavex.com

 

Investors:

Andrew J. Barwicki

Investor Relations

Tel: 516-662-9461

Email: andrew@barwicki.com

 

 

 

 EX-101.SCH 5 avxl-20220304.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 avxl-20220304_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 avxl-20220304_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Mar. 04, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 04, 2022
Entity File Number 001-37606
Entity Registrant Name ANAVEX LIFE SCIENCES CORP.
Entity Central Index Key 0001314052
Entity Tax Identification Number 98-0608404
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 630 5th Avenue
Entity Address, Address Line Two 20th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10111
City Area Code 844
Local Phone Number 689-3939
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AVXL
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 9 e3562_8-k_htm.xml IDEA: XBRL DOCUMENT 0001314052 2022-03-04 2022-03-04 iso4217:USD shares iso4217:USD shares 0001314052 false 8-K 2022-03-04 ANAVEX LIFE SCIENCES CORP. NV 001-37606 98-0608404 630 5th Avenue 20th Floor New York NY 10111 844 689-3939 false false false false Common Stock, par value $0.001 per share AVXL NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 122 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://anavex.com/role/Cover Cover Cover 1 false false All Reports Book All Reports e3562_8-k.htm avxl-20220304.xsd avxl-20220304_lab.xml avxl-20220304_pre.xml e3562_10-1.htm e3562_ex16-1.htm e3562_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "e3562_8-k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "e3562_8-k.htm" ] }, "labelLink": { "local": [ "avxl-20220304_lab.xml" ] }, "presentationLink": { "local": [ "avxl-20220304_pre.xml" ] }, "schema": { "local": [ "avxl-20220304.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "AVXL", "nsuri": "http://anavex.com/20220304", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e3562_8-k.htm", "contextRef": "From2022-03-04to2022-03-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://anavex.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e3562_8-k.htm", "contextRef": "From2022-03-04to2022-03-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://anavex.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0001731122-22-000366-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-22-000366-xbrl.zip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end